The invention relates to novel 1,4-diazepan-2-one compounds, which are TGR5 agonists and useful for the treatment of metabolic disorders, inflammatory diseases, atherosclerosis and dyslipidemias.
申请公布号
WO2016149628(A1)
申请公布日期
2016.09.22
申请号
WO2016US23165
申请日期
2016.03.18
申请人
CHEMBRIDGE CORPORATION
发明人
KASATKIN, Alexander;KURDYAVKA, Evgeny;SVIRIDOV, Sergei
